April, 20 2016, 11:45am EDT

Thursday Press Conference: World Leaders Call for Decriminalization and Regulation of Drugs during Historic UN Special Session
Former Presidents of Colombia, Mexico, and Switzerland together with Sir Richard Branson, US Former Federal Reserve Chair Paul Volcker and members of the Global Commission on Drug Policy call for reducing the harms caused by failed drug policy
WASHINGTON
On Thursday April 21 - the last day of the United Nations General Assembly Special Session (UNGASS) on drugs - several members of the Global Commission on Drug Policy will hold a press conference in New York. The Global Commission will evaluate the outcome of the UN meeting and call for concrete steps to ensure more effective drug policy reform in the years ahead. The UNGASS is taking place in New York from April 19-21 and is the first such gathering of governments in 18 years.
"Globally, we're wasting too much money and precious resources on criminalizing people and sending them to jail when we should be spending this money on helping people - through proper medical care and education," said Global Commission Member Sir Richard Branson. "From the perspective of an investor, the war on drugs has failed to deliver any returns. If it were one of my businesses, I would have shut it down many many years ago."
Commissioner and former President of Switzerland, Ruth Dreifuss also notes that "many countries are already successfully adopting innovative harm reduction and treatment strategies such as needle exchange, substitution therapies, heroin prescription and safe consumption rooms". She adds that "for these efforts to be truly effective, governments must decriminalize the use of drugs for personal use."
WHAT: Live press conference with leaders of the Global Commission on Drug Policy. LiveStreaming will also be available here: www.globalcommissionondrugs.org
WHEN: Thursday, April 21, 8:30am EDT. Breakfast and coffee available starting at 8am.
WHERE: Contact Tony Newman for information: 646-335-5384, press@globalcommissionondrugs.org
WHO:
- Ernesto Zedillo, Former President of Mexico
- Cesar Gaviria Trujillo, Former President of Colombia
- Richard Branson, Entrepreneur, founder of the Virgin Group, cofounder of The Elders, UK
- Paul Volcker, Former Chairman of the US Federal Reserve and the Economic Recovery Board, U.S.
- Louise Arbour, Former UN High Commissioner for Human Rights, Canada
- Michel Kazatchkine, professor of medicine, former executive director of the Global Fund to fight AIDS, tuberculosis and malaria
- Nick Clegg, Former Deputy Prime Minister of the UK
- Pavel Bem, Former Mayor of Prague, Czech Republic
- Ruth Dreifuss, Former President of Switzerland
The Global Commission is urging the United Nations and all member states to adopt a people-centered approach to drug policy. This means putting health, safety and human rights first. Drawing on evidence-based policies from around the world, the Commission is calling on governments to:
- End the criminalization and incarceration of drug users;
- Abolish capital punishment for drug-related offenses;
- Empower the World Health Organization (WHO) to review the scheduling system of drugs on the basis of scientific evidence;
- Ensure a broad spectrum of treatment for dependent people and services designed to reduce the harms of drugs; and
- Develop, test and implement different approaches to drug regulation in order to maximize public health and disempower organized crime.
The Global Commission believes the international drug policy regime has failed to achieve its original (and unrealistic) objectives of eradicating drug production and consumption. It has also generated alarming social, economic, political and health problems around the world. As former Presidents of Brazil, Colombia and Mexico noted in a recent Los Angeles Times op-ed: "outdated drug policies around the world have resulted in soaring drug-related violence, overstretched criminal justice systems, runaway corruption and mangled democratic institutions."
Over the past two decades many countries have started taking matters into their own hands. For example, Switzerland opened safe consumption rooms and offers maintenance and heroin assisted therapy in order to allow users to have a more healthy and balanced life. Portugal decriminalized the use of all drugs in 2001, with significant crime prevention and public health benefits including decreasing rates of HIV. Cannabis clubs have sprung-up around parts of Spain, and Uruguay has regulated its cannabis market from production, to distribution and sale.
Meanwhile, the U.S. is pioneering different approaches to regulating marijuana. Already 23 states plus Washington, D.C. have regulated marijuana for medicinal purposes; and four states (together with Washington, D.C). have regulated marijuana for recreational purposes. There is now unprecedented debate among elected officials, including President Obama, about how to transform drug policies to reduce mass incarceration in the U.S. What is more, Canada and Mexico are also exploring the regulation of marijuana for medical and personal use, driven in large part by high-levels of violence and favorable public opinion.
ABOUT THE GLOBAL COMMISSION ON DRUG POLICY
Founded in 2011, the Global Commission on Drug Policy is composed of political leaders and intellectuals from around the world including: the former Presidents of: Brazil, Mexico, Colombia, Chile, Portugal, Switzerland, Nigeria, Greece and Poland; former UN Secretary General Kofi Annan; former U.S. Secretary of State George Shultz; entrepreneur Sir Richard Branson; former Chairman of the U.S. Federal Reserve Paul Volcker; former Canadian Supreme Court Justice Louise Arbour; as well as leaders from Czech Republic, India, Norway, Pakistan, Peru, Spain and the UK.
The Global Commission made international headlines when it came out in support of decriminalization in 2011. In 2014, the Commission released a ground-breaking report that highlighted five pathways to effective drug policies including: harm reduction measures; equitable access to controlled medicines; decriminalization of people who use or possess drugs; alternatives to incarceration for low-level participants in illicit drug markets, and experiments in legally regulating markets of currently illicit drugs. Since its founding the Global Commission has produced five major reports and three internationally acclaimed films.
The Drug Policy Alliance is the nation's leading organization promoting drug policies grounded in science, compassion, health and human rights.
(212) 613-8020LATEST NEWS
Sanders Gets GOP Leader to Agree to Work On Medicare Covering Dental, Hearing, and Vision
The exchange on the Senate floor came after the Finance Committee chair blocked passage of the Vermont Independent's bill.
Mar 11, 2025
U.S. Senate Finance Committee Chair Mike Crapo on Tuesday blocked passage of Sen. Bernie Sanders' legislation to expand Medicare to cover dental, hearing, and vision care for tens of millions of American seniors, but the bill's sponsor got the panel leader to publicly agree to further discuss the issue.
Sanders (I-Vt.) took to the Senate floor Tuesday afternoon to ask for unanimous consent to pass the Medicare Dental, Hearing, and Vision Expansion Act, which is spearheaded in the House of Representatives by Congressman Lloyd Doggett (D-Texas).
"In the richest country in the history of the world, it is unacceptable that millions of seniors are unable to read because they can't afford eyeglasses, can't have conversations with their grandchildren because they can't afford hearing aids, and have trouble eating because they can't afford dentures," Sanders said in a statement.
"That should not be happening in the United States of America in the year 2025," he continued. "The time is long overdue for Congress to expand Medicare to include comprehensive coverage for the dental, vision, and hearing care that our seniors desperately need."
After Crapo (R-Idaho) rose to stop the bill from advancing, he and Sanders had a brief exchange in which the Republican agreed to working on achieving the "outcome" of the federal healthcare program covering dental, vision, and hearing.
In Sanders' remarks on the Senate floor about his bill, he sounded the alarm about efforts by President Donald Trump, billionaire Elon Musk, and congressional Republicans to cut government healthcare programs and Social Security.
"Yeah, we have more nuclear weapons than any other country, we have more billionaires than any other country, but we also have one of the highest rates of senior poverty of any country on Earth. We might want to get our priorities right," said Sanders, who has long fought for achieving universal healthcare in the United States via his Medicare for All legislation.
"While my Republican colleagues would like to make massive cuts to Medicaid in order to provide more tax breaks to billionaires, some of us have a better idea," he said. "We think that it makes more sense to substantially improve the lives of our nation's seniors by expanding Medicare to cover dental, vision, and hearing benefits."
To pay for his expansion plan, Sanders calls for ensuring that Medicare pays no more for prescription drugs than the Department of Veterans Affairs and addressing the tens of billions of dollars that privately administered Medicare Advantage plans overcharge the federal government annually.
In a statement about the bill, Doggett highlighted that "this expanded care could help prevent cognitive impairment and dementia, worsened chronic disease, and imbalance leading to falls with deadly consequences. This is an essential step to fulfilling the original promise of Medicare—to assure dignity and health for all."
Welcoming their renewed push for Medicare expansion, Public Citizen healthcare advocate Eagan Kemp declared that "at the same time Trump and his cronies in Congress try to rip healthcare away from millions and push for further privatization of Medicare, Sen. Sanders and Rep. Doggett are showing what one of our top priorities in healthcare should be—improving traditional Medicare."
"The introduction of this legislation is an important step to ensure Medicare enrollees can access the care they need, and we hope that Congress will act quickly to pass these commonsense reforms," Kemp added. "Healthcare is a human right."
Earlier Tuesday, in anticipation of Crapo's committee holding a confirmation hearing for Dr. Mehmet Oz, the former television host Trump has nominated to lead the Centers for Medicare and Medicaid, Public Citizen released a research brief about the hundreds of millions of dollars Medicare Advantage companies have spent on lobbying.
"If Oz is confirmed as the CMS administrator," Kemp warned, "attacks on traditional Medicare are likely to move into overdrive."
Keep ReadingShow Less
Trump Lifts Ukraine Aid Pause After Kyiv Agrees to Cease-Fire Proposal
Ukraine's foreign minister called the endorsement a "step that proves Ukraine is ready to move forward on the path to a just end to the war."
Mar 11, 2025
The Trump administration said Tuesday that it would resume military aid to and intelligence-sharing with Ukraine after that country's leadership endorsed a U.S. proposal for a 30-day cease-fire in the war defending against Russia's three-year invasion and occupation.
The Washington Postreports that U.S., Ukrainian, and Saudi officials met for eight hours on Tuesday in Jeddah, Saudi Arabia. No Russian officials were present at the negotiations.
"We're going to tell them this is what's on the table. Ukraine is ready to stop shooting and start talking," U.S. Secretary of State Marco Rubio said after the meeting. "And now it'll be up to them to say yes or no. If they say no, then we'll unfortunately know what the impediment is to peace here."
Ukraine has agreed to a 30 day ceasefire. Incredible work by Trump team. Now if Russia agrees, Trump may have gotten cease fires in the Middle East and Europe in his first 60 days. Nobel Peace Prize worthy: pic.twitter.com/lYogXVP8wj
— Clay Travis (@ClayTravis) March 11, 2025
White House National Security Adviser Michael Waltz said following the talks that "the Ukrainian delegation today made something very clear, that they share President [Donald] Trump's vision for peace, they share his determination to end the fighting, to end the killing, to end the tragic meat grinder of people."
Ukrainian Foreign Minister Andrii Sybiha called his country's endorsement of the cease-fire proposal a "step that proves Ukraine is ready to move forward on the path to a just end to the war."
"Ukraine is not an obstacle to peace; it is a partner in its restoration," Sybiha added.
U.S. officials said the cease-fire proposal will now be sent to Russia for approval. It is unclear whether Russian President Vladimir Putin will accept the offer.
"The ball is now in their court," Rubio said of the Russians.
Buoyed by Western support but stretched thin and vastly outmanned and outgunned, Ukrainian forces have been struggling to repel Russia's invasion and hold Russian territory they seized in the Kursk region, with an eye toward potential future territorial exchanges.
On Tuesday, Ukrainian forces launched a massive drone attack on Moscow. Three people were reportedly killed and six others were injured when debris struck a meat processing facility.
Tuesday's development marked a dramatic turnaround from just two weeks ago, when Trump and Vice President JD Vance lambasted Ukrainian President Volodymyr Zelenskyy during a highly contentious White House meeting that was followed by a suspension of all U.S. military assistance and intelligence-sharing with Kyiv.
The U.S. has "provided $66.5 billion in military assistance since Russia launched its premeditated, unprovoked, and brutal full-scale invasion of Ukraine on February 24, 2022, and approximately $69.2 billion in military assistance since Russia's initial invasion of Ukraine in 2014," according to a State Department fact sheet dated March 4.
Keep ReadingShow Less
Watchdog Exposes Millions in Medicare Advantage Lobbying Ahead of Dr. Oz Hearing
"If Oz is confirmed as the CMS administrator, attacks on traditional Medicare are likely to move into overdrive," said one advocate, calling to strengthen the program, "not weaken it through further privatization."
Mar 11, 2025
The watchdog group Public Citizen on Tuesday released a research brief about the hundreds of millions of dollars Medicare Advantage companies have spent on lobbying ahead of a U.S. Senate confirmation hearing for Dr. Mehmet Oz.
Oz, a heart surgeon and former television host, is President Donald Trump's nominee to run the Centers for Medicare and Medicaid (CMS)—an agency in the U.S. Department of Health and Human Services, which is led by conspiracy theorist Robert F. Kennedy Jr.
Health experts and others have sounded the alarm about Oz since Trump announceded his nomination in November, with many opponents highlighting the doctor's investments in companies with direct CMS interests and his push to expand Medicare Advantage when he unsuccessfully ran as a Republican to represent Pennsylvania in the U.S. Senate in 2022.
Medicare Advantage is a type of CMS-approved health insurance plan from a private company that seniors can choose for medical coverage instead of government-administered Medicare. Critics often call it a "profit-seeking healthcare scam."
Public Citizen's brief points out that last year, "more than half of all seniors eligible for Medicare were enrolled" in these private plans that "cost taxpayers hundreds of billions of dollars and deliver inferior care compared to traditional Medicare."
"Since their inception in 2003, Medicare Advantage plans are estimated to have cost taxpayers more than $600 billion in overpayments," the document notes. "These overpayments are expected to grow to $1 trillion over the next decade."
"Just seven companies account for 84% of all Medicare Advantage enrollment," the brief continues. "While lobbying disclosures do not reveal how much is spent on a single issue, disclosures reveal that these seven companies spent more than $330 million combined lobbying on all issues over the last five years, according to data from OpenSecrets."
Those companies are UnitedHealthcare, Humana, Blue Cross Blue Shield, CVS Health, Kaiser, Centene, and Cigna.
Public Citizen found that in 2024, they collectively had 328 lobbyists targeting the federal government, with nearly 70% of them specifically working on Medicare Advantage. Blue Cross had the most lobbyists focused on such plans (99), followed by Humana (33) and UnitedHealth Group (27).
"If Oz is confirmed as the CMS administrator, attacks on traditional Medicare are likely to move into overdrive," Eagan Kemp, a healthcare policy advocate at Public Citizen, warned in a Tuesday statement. "We should strengthen Medicare by improving it and expanding access to it, not weaken it through further privatization."
The Senate Committee on Finance is set to consider Oz on Friday morning. Since Trump returned to the White House in January, the GOP-controlled chamber hasn't blocked any of his nominees.
Keep ReadingShow Less
Most Popular